January 29, 2010
Bioniche E. coli O157 Vaccine Recognized in Prestigious Scientific Journal

November 25, 2009
Bioniche Strengthens the International Patent Portfolio for its MCC Technology Platform

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

I'm pleased to welcome you to the Bioniche Life Sciences website. We hope your visit provides you with an informative view of the company, our goals, our science and our focus on innovation. In 2009, Bioniche has reached its 30th year in business. Today, we have an expanding global presence, a dedicated employee base, an experienced leadership team, and a product and technology mix that is exceptional.

However, the original guiding principles of the company have not changed. In both human and animal health, we are committed to improving the quality of life through innovative research and therapeutics. This commitment guides our business decisions, serving as a beacon for determining the right actions, for staying on course, and for inspiring us to use our technologies and capabilities to help solve some of the world's most challenging healthcare problems.

Enjoy your visit, and please contact us if you would like to know more about Bioniche.

Sincerely,

Graeme McRae